
Darrell Mealer Wilson MD
Professor, Pediatrics - Endocrinology and Diabetes, Stanford University Medical Center
Join to View Full Profile
725 Welch RdPalo Alto, CA 94304
Phone+1 650-497-8000
Dr. Wilson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Pediatric Endocrinology, 1980 - 1984
Stanford Health Care-Sponsored Stanford UniversityResidency, Pediatrics, 1977 - 1980
University of California San Diego School of MedicineClass of 1977
University of CaliforniaB.S., Electrical Engineering, Highest Honors, 1969 - 1973
Certifications & Licensure
CA State Medical License 1978 - 2026
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Endocrinology
Awards, Honors, & Recognition
- America’s Best Doctors 1999-2018
- America's Top Doctors Castle Connolly, 2002-2014
- Honoree San Francisco Juvenile Diabetes Research Foundation, 2009
Clinical Trials
- TrialNet Pathway to Prevention of T1D Start of enrollment: 2004 Feb 01
- Treatment of Insulin Resistance in Hypertensive, Obese Adolescents Start of enrollment: 2006 Oct 01
- Glaser Obesity Study Start of enrollment: 2003 Oct 01
Publications & Presentations
PubMed
- 2 citationsContinuous glucose monitor metrics from five studies identify participants at risk for type 1 diabetes development.Peter Calhoun, Charles Spanbauer, Andrea K Steck, Brigitte I Frohnert, Mark A Herman
Diabetologia. 2025-05-01 - The Unfolding Story of Protein Misfolding Causing Alzheimer Disease in Recipients of Human Pituitary Growth Hormone.Evan G Graber, Sayed M Hadi Hosseini, Darrell M Wilson, Alan D Rogol
Journal of the Endocrine Society. 2025-02-04 - 4 citationsDiabetic Ketoacidosis at Diagnosis in Youth with Type 1 Diabetes Is Associated with a Higher Hemoglobin A1c Even with Intensive Insulin Management.Dessi P Zaharieva, Victoria Y Ding, Ananta Addala, Priya Prahalad, Franziska Bishop
Diabetes Technology & Therapeutics. 2024-03-01
Journal Articles
- Reactivation of Latent Viruses in Individuals Receiving Rituximab for New Onset Type 1 DiabetesKroll JL, Beam C, Li S, Viscidi R, Pescovitz M, Weinberg A, the Type 1 Diabetes TrialNet Anti CD-20 Study Group, J Clin Virol, 2/17/2013
- Epstein Barr and other Herpes Virus Infections in Early Onset Type I Diabetics Treated with Daclizumab and Mycophenolate MofetilLoechelt BJ, Boulware D, Green M, Baden LR, Gottlieb P, Krause-Steinrauf H, Weinberg A; for the Type I Diabetes TrialNet Daclizumab/Mycophenolic Acid Study Group, Clin Infect Dis, 10/5/2012
- The Landmark JDRF Continuous Glucose Monitoring Randomized Trials: a Look Back at the Accumulated EvidenceRuedy KJ, Tamborlane WV, for the Juvenile Diabetes Research Foundation The Landmark JDRF Continuous Glucose Monitoring Study Group, J of Cardiovasc Trans Res, 8/1/2012
Books/Book Chapters
Press Mentions
Clinical Startup of the 670G Closed Loop Insulin Delivery System (670Gstartup)January 7th, 2017
Grant Support
- Type 1 Diabetes Trialnet At StanfordNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2011
- Clinical Trial: Type 1 Diabetes: Cellcept Alone Or In Combination With DaclizumaNational Center For Research Resources2008
- Clinical Trial: Trialnet Screening To Assess Risk Of Type 1 DiabetesNational Center For Research Resources2008
- Clinical Trial: Trial Of Metformin In Obese Adolescentsmetformin In Obese AdolNational Center For Research Resources2008
- Clinical Trial: Shared Diabetes Trial StudiesNational Center For Research Resources2008
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









